Pyridostigmine bromide ER is a once-daily soman nerve agent pretreatment pyridostigmine product for the U.S. armed services and U.S. allies.

Amneal Pharmaceuticals said the U.S. Food and Drug Administration has approved its new drug application for its medication pyridostigmine bromide extended-release tablets. The pharmaceutical company ...

approval of its New Drug Application (NDA) for Pyridostigmine Bromide Extended-Release (PB ER) Tablets USP 105 mg. PB ER 105 mg tablets are a once-daily, orally administered product indicated for ...

the role of anticholinergic drugs in chronic asthma management has been largely underestimated. Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Does methscopolamine interact with other medicines (drug interactions)? Always tell your healthcare provider about any prescription or over-the-counter (OTC) medicines, vitamins/minerals ...

(RTTNews) - Amneal Pharmaceuticals (AMRX) announced it has received FDA approval of its New Drug Application for Pyridostigmine Bromide Extended-Release Tablets USP 105 mg. PB ER 105 mg tablets ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, ...

An adverse reaction is an undesirable reaction to a medication that's been taken correctly. It may occur immediately, hours, or years after starting a drug. Reactions might include minor side effects ...

The two medications are Fidoquel-CA1 (phenobarbital tablets) and KBroVet-CA1 (potassium bromide). Conditional approval means that the drug makers have shown that these medications are safe ...